Alyeska Investment Group, L.P.

Position in MRK — Merck & Co., Inc.

CIK 1453072 CHICAGO, IL

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$318,755,815

+$41,418,319 QoQ

Shares Held

2,480,590

+7.6% QoQ

Ownership

0.101%

of shares outstanding

% of Portfolio

0.91%

of 13F equity value

Holder Rank

#94

of 3,769 holders

Holding Since

Jun 2021

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $909,020,667 across 5 Drug Manufacturers - General names. MRK ranks #1 (35.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc. This page	2,480,590	$318,755,815
2	JNJ	Johnson & Johnson	1,173,482	$298,029,223
3	BIIB	Biogen Inc.	932,374	$201,448,726
4	SNY	Sanofi	2,112,012	$90,098,431
5	LLY	ELI LILLY & Co	574	$688,472

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$318,755,815	2,480,590	+7.6%	Shares	Sole	2026-08-14
2026-03-31	$277,337,496	2,305,574	+46.2%	Shares	Sole	2026-05-15
2025-12-31	$165,964,705	1,576,712	+5727.4%	Shares	Sole	2026-02-13
2024-03-31	$3,570,171	27,057	+487.7%	Shares	Sole	2024-05-15
2022-06-30	$419,746	4,604	-99.6%	Shares	Sole	2022-08-15
2021-09-30	$78,805,637	1,049,203	+97.3%	Shares	Sole	2021-11-15
2021-06-30	$41,348,598	531,678	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.